CYP2E1 -1293G>A/-1053C>T polymorphisms are associated to increased risk of developing acute myeloid leukemia (AML) and acute lymphocytic leukemia (ALL) [7, 8]. The gene discussed is CYP2E1; the disease is acute lymphoblastic leukemia.